“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing
2.1. Study Design and Theoretical Framework
2.2. Recruitment, Focus Group Structure, and Data Collection
2.3. Data Analysis and Rigor
3.1. Theme 1. Limited Information about Deprescribing: “I Think Deprescribing as a whole Is a Gap!”
“I think deprescribing as a whole is a gap! When I was reading the name of this study, it was talking about deprescribing in your curriculum, and I literally was like, when did we talk about deprescribing in the curriculum? And you mentioned like, what tools do you have to reference? I honestly didn’t even know there were tools we could reference. So I think just as a whole it’s a gap”.(ST4, FG2, P3)
“…100% agree with (ST4)…We don’t have any kind of—yeah, the whole thing is a gap, we don’t have any kind of experience with deprescribing in the actual curriculum”.(ST2, FG2, P4)
“Yeah, kind of what ST4 and ST2 were talking about…I was reading an article about deprescribing, I don’t know anything about this…And like there’s no tools, we couldn’t go back on our notes. But I think just the term itself hasn’t been really used in our curriculum”.(ST5, FG2, P5)
“I know like I had mentioned polypharmacy or Beers Criteria and like geriatric studies, that kind of thing obviously hint to deprescribing, and a lot of it is like plugged into our curriculum, but I think being aware of the term itself and what falls below that and kind of referencing that would be really helpful, or else you’ll end up like us, googling and looking at articles right before this study”.(ST3, FG2, P4)
“…there hasn’t been any class or any lectures during class that focused on deprescribing so far…”(ST1, FG3, P2)
“I haven’t personally had, you know, an in-person experience deprescribing. So…I have no experience with deprescribing, so, yeah”.(ST3, FG3, P4)
“…I’m going to be honest… we didn’t really go too much into it. I believe we had two lectures in our therapeutics class really going over general just deprescribing, when it’s a good option to follow that route, and they also gave us some helpful websites as far as how to go about deprescribing some specific medications, but there really wasn’t a lot of in-depth training that I received from that. Honestly, I don’t think it’s really talked about too much. I’m not sure”.(ST4, FG1, P4)
“…we were given different scales, we were given MedStopper, and there was another application, Polypharmacy Guidance, that can all be used when deprescribing”.(ST4, FG4, P4)
“Several students were curious about how deprescribing is taught in other healthcare curricula and, specifically, about the depth of training received by the medical students. This excerpt emphasizes the perceived sense of importance a student placed on training on deprescribing in the pharmacy curriculum and its integration in the healthcare system and care for patients in the context of supporting pharmacist-provided patient care”.(ST3, FG1, P4)
“…I think it’s very important for them [medical students]—for us to know, as well, and for them to know in their curriculum what kind of training they get. Do I know what kind of training they get? No, but I’m assuming that, if we’re going to pick any profession, definitely the prescribers, the ones who are actually writing the medication, need the most extensive training”.(ST3, FG1, P4)
“I would agree, yes, there is a gap… I’m sure how beneficial it would be to know what the other professions are actually taught as far as deprescribing”.(ST4, FG1, P4)
3.2. Theme 2. Empowering Student Pharmacists through Emphasizing Deprescribing in the Pharmacy Curriculum
“I also think it needs to be something that’s brought up to the preceptors, kind of like what (ST3, FG2, P4) was saying is that, I mean, if the preceptor is pushing you to deprescribe and get people off certain medications they don’t need to be on, and it’s every preceptor… has that as part of like maybe their eval or some sort of that, and I think that will also help influence just the natural culture of deprescribing and bring it more to the forefront…And I think that, if-- I mean, and it starts with us, but it also starts with our preceptors, too, because they’re the ones that push us and mold us into the future pharmacist”.(ST1, FG2, P4)
“…I completely agree with ST2, and I completely agree with what ST1 said. Also speaking to ST1′s point, even if we add a lecture-- so we talk about it like oncology… we’re in neuro and psych…And so, even if you add something in, right now we’re learning about mental disorders, so something like a very-- you know, one lecture saying, for the mental disorders, these are the special consideration drugs for deprescribing. So at least somewhere to start, you know, start that lecture and then maybe we can incorporate that into an elective or a longer course, something just to get it started”.(ST4, FG2, P3)
5. Strength, Limitation, and Future Studies
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
- What training have you received on deprescribing in your pharmacy curriculum?
- What courses? What year? How in depth was the training?
- Have you been assessed on deprescribing in your pharmacy curriculum?
- When working as a pharmacy intern what experiences have you encountered with deprescribing?
- Saraf, A.A.; Petersen, A.W.; Simmons, S.F.; Schnelle, J.F.; Bell, S.P.; Kripalani, S.; Myers, A.P.; Mixon, A.S.; Long, E.A.; Jacobsen, J.M.L. Medications associated with geriatric syndromes and their prevalence in older hospitalized adults discharged to skilled nursing facilities. J. Hosp. Med. 2016, 11, 694–700. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Center for Disease Control. Prescription Drug Use among Adults Aged 40–79 in the United States and Canada. Available online: https://www.cdc.gov/nchs/products/databriefs/db347.htm (accessed on 22 April 2022).
- 2019 American Geriatrics Society Beers Criteria® Update Expert Panel; Fick, D.M.; Semla, T.P.; Steinman, M.; Beizer, J.; Brandt, N.; Dombrowski, R.; DuBeau, C.E.; Pezzullo, L.; Epplin, J.J.; et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 2019, 67, 674–694. [Google Scholar]
- Harrison, S.L.; Kouladjian O’Donnell, L.; Bradley, C.E.; Milte, R.; Dyer, S.M.; Gnanamanickam, E.S.; Liu, E.; Hilmer, S.N.; Crotty, M. Associations between the drug burden index, potentially inappropriate medications and quality of life in residential aged care. Drugs Aging 2018, 35, 83–91. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Scott, I.A.; Hilmer, S.N.; Reeve, E.; Potter, K.; Le Couteur, D.; Rigby, D.; Gnjidic, D.; Del Mar, C.B.; Roughead, E.E.; Page, A. Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Intern. Med. 2015, 175, 827–834. [Google Scholar] [CrossRef][Green Version]
- Thillainadesan, J.; Gnjidic, D.; Green, S.; Hilmer, S.N. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: A systematic review of randomised trials. Drugs Aging 2018, 35, 303–319. [Google Scholar] [CrossRef]
- Munshi, M.N.; Slyne, C.; Segal, A.R.; Saul, N.; Lyons, C.; Weinger, K. Simplification of insulin regimen in older adults and risk of hypoglycemia. JAMA Intern. Med. 2016, 176, 1023–1025. [Google Scholar] [CrossRef]
- Kutner, J.S.; Blatchford, P.J.; Taylor, D.H.; Ritchie, C.S.; Bull, J.H.; Fairclough, D.L.; Hanson, L.C.; LeBlanc, T.W.; Samsa, G.P.; Wolf, S. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: A randomized clinical trial. JAMA Intern. Med. 2015, 175, 691–700. [Google Scholar] [CrossRef][Green Version]
- Acreditation Council for Pharmacy Education. Acreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. Available online: https://www.acpe-accredit.org/pdf/Standards2016FINAL.pdf (accessed on 28 February 2022).
- Woodall, T.; Pokallus, A.; Rice, S.; Scott, M.A. The current state of geriatric pharmacy education in the United States–A cross-sectional survey. Curr. Pharm. Teach. Learn. 2022, 14, 258–263. [Google Scholar] [CrossRef]
- Zimmerman, K.M.; Bell, C.A.; Donohoe, K.L.; Salgado, T.M. Medicine, pharmacy and nursing trainees’ perceptions of curriculum preparation to deprescribe and interprofessional roles in the deprescribing process. Gerontol. Geriatr. Educ. 2020, 41, 63–84. [Google Scholar] [CrossRef]
- Clark, C.M.; Hejna, M.; Shao, E.; Maerten-Rivera, J.L.; Monte, S.V.; Wahler, R.G. Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study. Pharmacy 2020, 8, 220. [Google Scholar] [CrossRef]
- Krueger, R.A. Analyzing focus group interviews. J. Wound Ostomy Continence Nurs. 2006, 33, 478–481. [Google Scholar] [CrossRef] [PubMed]
- Lobe, B.; Morgan, D.; Hoffman, K.A. Qualitative Data Collection in an Era of Social Distancing. Int. J. Qual. Methods 2020, 19, 1–8. [Google Scholar] [CrossRef]
- Ajzen, I. The theory of planned behavior. Organ. Behav. Hum. Decis. Processes 1991, 50, 179–211. [Google Scholar] [CrossRef]
- Siuki, H.A.; Peyman, N.; Vahedian-Shahroodi, M.; Gholian-Aval, M.; Tehrani, H. Health education intervention on HIV/AIDS prevention behaviors among health volunteers in healthcare centers: An applying the theory of planned behavior. J. Soc. Serv. Res. 2019, 45, 582–588. [Google Scholar] [CrossRef]
- Casper, E.S. The theory of planned behavior applied to continuing education for mental health professionals. Psychiatr. Serv. 2007, 58, 1324–1329. [Google Scholar] [CrossRef] [PubMed]
- George, D.L.; Smith, M.J.; Draugalis, J.R.; Tolma, E.L.; Keast, S.L.; Wilson, J.B. Community pharmacists’ beliefs regarding improvement of Star Ratings scores using the Theory of Planned Behavior. J. Am. Pharm. Assoc. 2018, 58, 21–29. [Google Scholar] [CrossRef]
- Chu, A.; Gupta, V.; Unni, E.J. Utilizing the Theory of Planned Behavior to determine the intentions to receive the influenza vaccine during COVID-19: A cross-sectional survey of US adults. Prev. Med. Rep. 2021, 23, 101417. [Google Scholar] [CrossRef]
- Rich, A.; Brandes, K.; Mullan, B.; Hagger, M.S. Theory of planned behavior and adherence in chronic illness: A meta-analysis. J. Behav. Med. 2015, 38, 673–688. [Google Scholar] [CrossRef][Green Version]
- Archibald, M.M.; Ambagtsheer, R.C.; Casey, M.G.; Lawless, M. Using zoom videoconferencing for qualitative data collection: Perceptions and experiences of researchers and participants. Int. J. Qual. Methods 2019, 18, 1609406919874596. [Google Scholar] [CrossRef][Green Version]
- Morgan, D.L. Focus groups. Annu. Rev. Sociol. 1996, 22, 129–152. [Google Scholar] [CrossRef]
- Birks, M.; Chapman, Y.; Francis, K. Memoing in qualitative research: Probing data and processes. J. Res. Nurs. 2008, 13, 68–75. [Google Scholar] [CrossRef]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef][Green Version]
- Hsieh, H.-F.; Shannon, S.E. Three approaches to qualitative content analysis. Qual. Health Res. 2005, 15, 1277–1288. [Google Scholar] [CrossRef] [PubMed]
- O’Brien, B.C.; Harris, I.B.; Beckman, T.J.; Reed, D.A.; Cook, D.A. Standards for reporting qualitative research: A synthesis of recommendations. Acad. Med. 2014, 89, 1245–1251. [Google Scholar] [CrossRef] [PubMed]
- Poots, A.J.; Jubraj, B.; Ward, E.; Wycoco, A.; Barnett, N. Education around medication review and deprescribing: A survey of medical and pharmacy students’ perspectives. Ther. Adv. Drug Saf. 2020, 11, 2042098620909610. [Google Scholar] [CrossRef]
- Farrell, B.; Conklin, J.; Dolovich, L.; Irving, H.; Maclure, M.; McCarthy, L.; Moriarty, F.; Pottie, K.; Raman-Wilms, L.; Reeve, E. Deprescribing guidelines: An international symposium on development, implementation, research and health professional education. Res. Soc. Adm. Pharm. 2019, 15, 780–789. [Google Scholar] [CrossRef][Green Version]
- Canadian Deprescribing Network. Do I still Need This Medication. Available online: https://www.deprescribingnetwork.ca/pharmaceutical-opinions (accessed on 17 May 2022).
- New South Wales Therapeutic Advisory Group. Deprescribing Tools. Available online: https://www.nswtag.org.au/deprescribing-tools/ (accessed on 18 May 2022).
- Green, A.R.; Boyd, C.M.; Gleason, K.S.; Wright, L.; Kraus, C.R.; Bedoy, R.; Sanchez, B.; Norton, J.; Sheehan, O.C.; Wolff, J.L. Designing a primary care–based deprescribing intervention for patients with dementia and multiple chronic conditions: A qualitative study. J. Gen. Intern. Med. 2020, 35, 3556–3563. [Google Scholar] [CrossRef]
- Mecca, M.C.; Thomas, J.M.; Niehoff, K.M.; Hyson, A.; Jeffery, S.M.; Sellinger, J.; Mecca, A.P.; Van Ness, P.H.; Fried, T.R.; Brienza, R. Assessing an interprofessional polypharmacy and deprescribing educational intervention for primary care post-graduate trainees: A quantitative and qualitative evaluation. J. Gen. Intern. Med. 2019, 34, 1220–1227. [Google Scholar] [CrossRef][Green Version]
- Battar, S.; Dickerson, K.R.W.; Sedgwick, C.; Cmelik, T. Understanding principles of high reliability organizations through the eyes of VIONE: A clinical program to improve patient safety by deprescribing potentially inappropriate medications and reducing polypharmacy. Fed. Pract. 2019, 36, 564. [Google Scholar]
- Bruyere Research Institute. Polypharmacy and Deprescribing. Available online: https://www.bruyere.org/en/polypharmacy-deprescribing (accessed on 18 May 2022).
- O’Mahony, D.; O’Sullivan, D.; Byrne, S.; O’Connor, M.N.; Ryan, C.; Gallagher, P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2014, 44, 213–218. [Google Scholar] [CrossRef][Green Version]
- Medstopper. Medstopper Plan. Available online: https://medstopper.com/ (accessed on 18 May 2022).
- Pruskowski, J.; Sakely, H.; Handler, S. Development of a required longitudinal residency experience focused on deprescribing. Am. J. Health Syst. Pharm. 2019, 76, 236–241. [Google Scholar] [CrossRef] [PubMed]
- Zimmerman, K.M.; Linsky, A.M.; Donohoe, K.L.; Hobgood, S.E.; Sargent, L.; Salgado, T.M. An interprofessional workshop to enhance de-prescribing practices among health care providers. J. Contin. Educ. Health Prof. 2020, 40, 49–57. [Google Scholar] [CrossRef] [PubMed]
- Sun, W.; Grabkowski, M.; Zou, P.; Ashtarieh, B. The Development of a Deprescribing Competency Framework in Geriatric Nursing Education. West. J. Nurs. Res. 2021, 43, 1043–1050. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Springer, S.P.; Cernasev, A.; Barenie, R.E.; Axon, D.R.; Scott, D. “I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing. Geriatrics 2022, 7, 60. https://doi.org/10.3390/geriatrics7030060
Springer SP, Cernasev A, Barenie RE, Axon DR, Scott D. “I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing. Geriatrics. 2022; 7(3):60. https://doi.org/10.3390/geriatrics7030060Chicago/Turabian Style
Springer, Sydney P., Alina Cernasev, Rachel E. Barenie, David R. Axon, and Devin Scott. 2022. "“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing" Geriatrics 7, no. 3: 60. https://doi.org/10.3390/geriatrics7030060